The evaluation of coagulation ability at leaving crdio-pulmonary bypass in cardiovascular surgery

The evaluation of coagulation ability at leaving crdio-pulmonary bypass in cardiovascular surgery - The evaluation of coagulation ability at leaving crdio-pulmonary bypass in cardiovascular surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021680

Enrollment

Registered

2016-04-25

Start date

2016-04-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute aortic disection Thoracic aortic aneurysm re-cardio-vascular surgery

Interventions

befor leaving cardio-pulmonary bypass, FFP4Unit is administrated. after leaving cardio-pulmonary bypass, FFP4Unit is administrated. befor leaving cardio-pulmonary bypass, FFP isn&#39

t administrated. after leaving cardio-pulmonary bypass, FFP8Unit is administrated.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cardiovascular surgery cases with using FFP and/or PC : Acute aortic disection, Thorasic aortic aneurysm, Re-cardiovascular surgery

Exclusion criteria

Exclusion criteria: incompatibility using FFP, PC, heaprin, protamine When FFP and PC deviate from the prescribed time. The patient is judged that joining to this study is inappropriate

Design outcomes

Primary

Measure	Time frame
result of thromboelastography after leaving cardio pulmonary bypass and administrating protamine	—

Secondary

Measure	Time frame
relationship with other blood examination total of bleeding amount of postoperative transfusion	—

Countries

Japan

Contacts

Public ContactTakahiro Tamura

Japanease red cross nagoya daiichi hospital Anesthesiology

takahiro@nagoya-1st.jrc.or.jp0524815111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026